Literature DB >> 11999357

Successful immunosuppressive therapy with cyclosporine A for posthepatitis B-cell deficiency with activated cytoplasmic interferon--gamma-positive T-lymphocytes.

Hiroko Otsubo1, Ken Kaito, Yoji Ogasawara, Takaki Shimada, Noriko Usui, Masayuki Kobayashi.   

Abstract

We describe a patient with transient disappearance of B-cells, hypogammaglobulinemia, and mild pancytopenia after acute hepatitis. Both HLA-DR+CD8+ and intracellular interferon-gamma+/interleukin-4- cell levels were markedly increased, resulting in an increase in the cytotoxic T-cell (T(C))1/Tc2 and helper T-cell (T(H))1/T(H)2 ratios. After immunosuppressive therapy with cyclosporine A, these parameters of T-cell activation were clearly decreased, and hematologic recovery, including an increase in B-lymphocytes and immunoglobulin concentration, was obtained. These results suggest that there had been suppression of B-cells by activated T-cells. Some patients with common variable immunodeficiency show similar activation of T-cell function, and the present findings suggest the possibility of immunosuppressive therapy for such patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999357     DOI: 10.1007/bf02982043

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  CD8+ T cell populations in common variable immunodeficiency.

Authors:  S Werwitzke; B Drescher; R E Schmidt; T Witte
Journal:  Immunobiology       Date:  2000-08       Impact factor: 3.144

3.  Common variable immunodeficiency following Epstein-Barr virus infection.

Authors:  G Zuccaro; S Della Bella; B Polizzi; M Vanoli; R Scorza
Journal:  J Clin Lab Immunol       Date:  1997

Review 4.  Primary immunodeficiency diseases. Report of a WHO scientific group.

Authors: 
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

5.  Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

Authors:  N Frickhofen; J P Kaltwasser; H Schrezenmeier; A Raghavachar; H G Vogt; F Herrmann; M Freund; P Meusers; A Salama; H Heimpel
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

6.  Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Hepatitis-associated aplastic anemia.

Authors:  K E Brown; J Tisdale; A J Barrett; C E Dunbar; N S Young
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

8.  IL-10 production and CD40L expression in patients with common variable immunodeficiency.

Authors:  A Oliva; E Scala; I Quinti; R Paganelli; I J Ansotegui; A Giovannetti; M Pierdominici; F Aiuti; F Pandolfi
Journal:  Scand J Immunol       Date:  1997-07       Impact factor: 3.487

9.  Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry.

Authors:  M E North; K Ivory; M Funauchi; A D Webster; A C Lane; J Farrant
Journal:  Clin Exp Immunol       Date:  1996-09       Impact factor: 4.330

10.  Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes.

Authors:  I Nordøy; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.